Disease-free survival (DFS) does not differ with adjuvant nivolumab plus ipilimumab (NIVO+IPI) compared with placebo in patients with localized renal cell carcinoma (RCC) at high risk for postnephrectomy relapse, according ...
Sep 14, 2022
0
9
A blood-based multicancer early detection (MCED) test using cell-free DNA (cfDNA) is feasible for outpatients and has a positive predictive value of about 40 percent, according to a study presented at the annual meeting of ...
Sep 14, 2022
0
15
Even though New York Governor Kathy Hochul recently declared polio a state emergency after samples of the virus were found in wastewater in New York City and four surrounding counties, public health experts say it's not time ...
Sep 13, 2022
0
7
New York Gov. Kathy Hochul said Friday the state was stepping up its polio-fighting efforts as the virus that causes the life-threatening disease was detected in the wastewater of yet another county in the New York City area.
Sep 9, 2022
0
11
A cap-and-invest strategy to cut transportation-related carbon emissions could provide substantial health benefits to children in New York City, with greater benefits among Black and Hispanic children. The results of the ...
Sep 7, 2022
0
4
New York state is dropping its mask requirement on public transportation thanks in part to the availability of new booster shots targeting the most common strain of COVID-19, Gov. Kathy Hochul announced Wednesday.
Sep 7, 2022
0
0
State health officials in New York are warning of expanding "community spread" of the polio virus after it was found in wastewater samples from another upstate county.
Aug 26, 2022
0
72
The virus that causes polio has been found in New York City's wastewater in another sign that the disease, which hadn't been seen in the U.S. in a decade, is quietly spreading among unvaccinated people, health officials said ...
Aug 12, 2022
0
5
Long-term follow up of patients with extensive stage small cell lung cancer who were given pembrolizumab and etoposide/platinum (EP) versus placebo + etoposide/platinum as first-line therapy support the continued exploration ...
Aug 9, 2022
0
7
Using sotorasib as a lead-in therapy with pembrolizumab or atezolizumab for patients with advanced KRAS p.G12C non-small cell lung cancer demonstrated durable clinical activity with lower rates of grade 3-4 treatment-related ...
Aug 8, 2022
0
8
